Nkgen Biotech Inc. posts Q1 net income of USD 15.4 million, up nearly 4 times
I'm PortAI, I can summarize articles.
Nkgen Biotech Inc. reported a Q1 net income of USD 15.4 million, nearly four times higher than the previous year. The earnings report for the quarter ending March 31, 2025, also noted total other income (expense) of USD 20.0 million, with no significant changes in research and development expenses and no provision for income taxes.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments